Skip to main content
Premium Trial:

Request an Annual Quote

David Thomassen Succeeds Patrinos at DOE; Steve Burrill Leaves Clinical Data; BioSeek Adds Directors; Luminex Forms New Advisory Board; and Others

NEW YORK, Feb. 8 (GenomeWeb News) - David Thomassen will replace Ari Patrinos at the Department of Energy's Office of Biological and Environmental Research until a permanent successor is chosen, a DOE spokesperson said on Monday.


Thomassen was formerly chief scientist at the office and coordinator of the of the Genomics:GTL project. Prior to his joining the DOE he held positions at the National Institute of Environmental Health Sciences, the National Cancer Institute and the Inhalation Toxicology Research Institute.


Thomassen holds a BS in zoology and a MS in genetics from Washington State University. He holds a PhD in genetics from the University of Wisconsin at Madison.


As GenomeWeb News reporterd, Patrinos will become president of Craig Venter's startup Synthetic Genomics Feb. 9.


Steve Burrill resigned his seat as a director of Clinical Data, the company announced last week.


The resignation was the result of a request "by his partners to limit his board commitments and participation only to companies in which Burrill & Company has a substantial financial interest," Clinical Data said in a statement.


Burrill was the chairman of Icoria, which Clinical Data acquired in December.


BioSeek named Michael Gallatin and Roy Whitfield to its board of directors, the company said Monday.


Gallatin was most recently vice president and scientific director at ICOS. Prior to that he was a faculty member at Fred Hutchinson Cancer Research Center. He has also joined BioSeek's advisory board, Bioseek said.


Whitfield most recently served as CEO and chairman of Incyte, which he co-founded in 1991.

He will serve as business advisor to Bioseek.

Luminex announced the formation of a new scientific advisory board yesterday.

It is comprised of Thomas Caskey, Ronald Bowsher, Andrea Ferreira-Gonzalez, Thomas Joos and Gary Procop. The chairman of the new board is James Jacobson, vice president of R&D at Luminex.


Thomas Caskey is director of the Brown Foundation Institute of Molecular Medicine at the University of Texas Health Science Center. He has served as president of the American Society of Human Genetics, the Human Genome Organization, and the Academy of Medicine, Engineering and Science of Texas.


Ronald Bowsher is a partner of Bowsher Brunelle Smith and a fellow of the American Association of Pharmaceutical Sciences. He was at Lilly Research Labs until his retirement in 2003.


Ferreira-Gonzalez is a professor of pathology at Virginia Commonwealth University and director of the VCU molecular diagnostics lab. She has served as a member of the clinical laboratory improvement advisory committee at HHS.


Joos is head of the biochemistry department of the NMI Institute at the University of Tubingen. He is a scientific advisor of BioChipNet and a member of the scientific advisory board of the Plasma Proteome Institute in Washington DC.


Procop is head of clinical microbiology at the Cleveland Clinic, which he joined in 1988. Prio to that he was pathology resident at Duke University Medical Center and at Mayo Clinic.

Sirna Therapeutics named Gregory Weaver senior vice president and chief financial officer, the company said yesterday. He will report to CEO Howard Robin.


Weaver most recently served as chief financial officer of Nastech Pharmaceutical. Prior to that he was chief financial officer at ILEX Oncology.

Akshay Vaishaw was named vice president of clinical research at Alnylam Pharmaceuticals, the company said yesterday.


Vaishaw comes to Alnylam from Biogen Idec where he was most recently senior director of translational medicine.

Douglas Sweet has joined Celerus Diagnostics as head of sales and marketing, the company announced yesterday.


Sweet has held senior positions at Molecular Devices, Syva, New England Nuclear and Corning Medical. He has advised several private companies entering the diagnostics industry,

GeneService appointed Andy Richards non-executive chairman, the Cambridge, UK-based company said last week.


Richards is a director of the UK Bioindustry Association. He was a founder of several Cambridge biotechnology companies including Chiroscience, Arakis, Cambridge Biotechnology and Daniolabs. He holds a number of non-executive director positions including Vectura Group, Daniolabs, Biowisdom, Babraham Bioscience Technology and Cancer Research Technology (the commercial arm of CR-UK). 

Thomas Brown joined Cepheid's board of directors, the company said yesterday.


Brown was senior vice president and president diagnostic operations at Abbot Labs until his retirement in 2002. He had been at the company since 1974 in a range of positions.


Brown currently serves on the Board of Directors for Ventana Medical Systems and Quidel Corporation and is vice chairman of the Condell Medical Center.

Cate Sabatini was named executive vice president of business development at Iconix, the company said last week.


Previously, Sabatini held positions positions with Incyte, where she was the director of product development and vice president of customer relations. Prior to Incyte, she was the manager of information systems at LSI Logic and a project manager for clinical systems at Syntex (Roche Group). She also founded Athena Consulting, where she worked with Genentech, Applera, Iconix and Align Technology in the areas of strategic planning, business development and sales and marketing.

Genologics has named Don Listwin to its board of directors, the company said last week.


Listwin was executive vice president at Cisco Systems until 2000. Most recently, Listwin served as the former president and CEO of Openwave Systems. He is the founder of the Canary Foundation, a non-profit foundation dedicated to early detection of cancer.


A native of Canada, Listwin holds a B.S. in electrical engineering and an honorary doctorate of law from the University of Saskatchewan.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.